Nicole Teasdale
Family · Canton, MINPI 1265719900
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,336 and has fallen 58.3% since, to $557 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$916
- Lilly USA, LLC$606
- AbbVie$537
- GSK$501
- Sunovion Pharmaceuticals Inc.$481
- Biohaven Pharmaceutical Holding Company Ltd.$272
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,483100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $916 |
| Lilly USA, LLC | 39 | $606 |
| AbbVie | 33 | $537 |
| GSK | 16 | $501 |
| Sunovion Pharmaceuticals Inc. | 31 | $481 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $272 |
| Biohaven Pharmaceuticals, Inc. | 8 | $233 |
| Exact Sciences | 11 | $225 |
| AstraZeneca | 10 | $195 |
| Pfizer | 6 | $126 |
| Corcept Therapeutics | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Edwards Lifesciences | 3 | $43 |
| Amgen | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Novartis | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$362
- NURTEC ODT$242
- UBRELVY$125
- Wegovy$114
How this compares
$4,483 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 32 | $486 |
| Atorvastatin Calcium | 15 | $166 |
| Lisinopril | 13 | $141 |
Paid to pharmacies, not to this prescriber.
Other family in Canton
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.